PuSH - Publikationsserver des Helmholtz Zentrums München

Eussen, S.J.P.M.* ; Vollset, S.E.* ; Igland, J.* ; Meyer, K.* ; Fredriksen, A.* ; Ueland, P.M.* ; Jenab, M.* ; Slimani, N.* ; Boffetta, P.* ; Overvad, K.* ; Tjønneland, A.* ; Olsen, A.* ; Clavel-Chapelon, F.* ; Boutron-Ruault, M.C.* ; Morois, S.* ; Weikert, C.* ; Pischon, T.* ; Linseisen, J. ; Kaaks, R.* ; Trichopoulou, A.* ; Zilis, D.* ; Katsoulis, M.* ; Palli, D.* ; Berrino, F.* ; Vineis, P.* ; Tumino, R.* ; Panico, S.* ; Peeters, P.H.M.* ; Bueno-de-Mesquita, H.B.* ; van Duijnhoven, F.J.* ; Gram, I.T.* ; Skeie, G.* ; Lund, E.* ; González, C.A.* ; Martinez, C.* ; Dorronsoro, M.* ; Ardanaz, E.* ; Navarro, C.* ; Rodriguez, L.* ; van Guelpen, B.* ; Palmqvist, R.* ; Manjer, J.* ; Ericson, U.* ; Bingham, S.* ; Khaw, K.T.* ; Norat, T.* ; Riboli, E.*

Plasma folate, related genetic variants, and colorectal cancer risk in EPIC.

Cancer Epidemiol. Biomarkers Prev. 19, 1328-1340 (2010)
Verlagsversion DOI
Free by publisher
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
BACKGROUND: A potential dual role of folate in colorectal cancer (CRC) is currently subject to debate. We investigate the associations between plasma folate, several relevant folate-related polymorphisms, and CRC risk within the large European Prospective Investigation into Cancer and Nutrition cohort. METHODS: In this nested case-control study, 1,367 incident CRC cases were matched to 2,325 controls for study center, age, and sex. Risk ratios (RR) were estimated with conditional logistic regression and adjusted for smoking, education, physical activity, and intake of alcohol and fiber. RESULTS: Overall analyses did not reveal associations of plasma folate with CRC. The RR (95% confidence interval; Ptrend) for the fifth versus the first quintile of folate status was 0.94 (0.74-1.20; 0.44). The polymorphisms MTHFR677C-->T, MTHFR1298A-->C, MTR2756A-->G, MTRR66A-->G, and MTHFD11958G-->A were not associated with CRC risk. However, in individuals with the lowest plasma folate concentrations, the MTHFR 677TT genotype showed a statistically nonsignificant increased CRC risk [RR (95% CI; Ptrend) TT versus CC=1.39 (0.87-2.21); 0.12], whereas those with the highest folate concentrations showed a nonsignificant decreased CRC risk [RR TT versus CC=0.74 (0.39-1.37); 0.34]. The SLC19A180G-->A showed a positive association with CRC risk [RR AA versus GG 1.30 (1.06-1.59); <0.01]. CONCLUSIONS: This large European prospective multicenter study did not show an association of CRC risk with plasma folate status nor with MTHFR polymorphisms. IMPACT: Findings of the present study tend to weaken the evidence that folate plays an important role in CRC carcinogenesis. However, larger sample sizes are needed to adequately address potential gene-environment interactions.
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Methylenetetrahydrofolate reductase polymorphism; Nested case-control; Human methionine synthase; Carbon metabolic pathway; C677T MTHFR polymorphism; Colon-cancer; Folic-acid; Mass-spectrometry; Dietary patterns; Common mutation
ISSN (print) / ISBN 1055-9965
e-ISSN 1538-7755
Quellenangaben Band: 19, Heft: 5, Seiten: 1328-1340 Artikelnummer: , Supplement: ,
Verlag American Association for Cancer Research (AACR)
Begutachtungsstatus Peer reviewed